GYNE-LOTRIMIN 3 COMBINATION PACK Drug Patent Profile
✉ Email this page to a colleague
When do Gyne-lotrimin 3 Combination Pack patents expire, and when can generic versions of Gyne-lotrimin 3 Combination Pack launch?
Gyne-lotrimin 3 Combination Pack is a drug marketed by Bayer Healthcare Llc and is included in one NDA.
The generic ingredient in GYNE-LOTRIMIN 3 COMBINATION PACK is clotrimazole. There are eleven drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the clotrimazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Gyne-lotrimin 3 Combination Pack
A generic version of GYNE-LOTRIMIN 3 COMBINATION PACK was approved as clotrimazole by P AND L on July 16th, 1993.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GYNE-LOTRIMIN 3 COMBINATION PACK?
- What are the global sales for GYNE-LOTRIMIN 3 COMBINATION PACK?
- What is Average Wholesale Price for GYNE-LOTRIMIN 3 COMBINATION PACK?
Summary for GYNE-LOTRIMIN 3 COMBINATION PACK
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 126 |
| Clinical Trials: | 4 |
| Patent Applications: | 4,223 |
| DailyMed Link: | GYNE-LOTRIMIN 3 COMBINATION PACK at DailyMed |
Recent Clinical Trials for GYNE-LOTRIMIN 3 COMBINATION PACK
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Bayer | Phase 3 |
| Taro Pharmaceuticals USA | Phase 1 |
US Patents and Regulatory Information for GYNE-LOTRIMIN 3 COMBINATION PACK
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Healthcare Llc | GYNE-LOTRIMIN 3 COMBINATION PACK | clotrimazole | CREAM, TABLET;TOPICAL, VAGINAL | 020526-002 | Jul 29, 1996 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
